Earnings · China A-shares
Shenzhen Kangtai Biological Products Co. Ltd. Class A (300601) earnings
Shenzhen Kangtai Biological Products Co. Ltd. Class A published its Q3 report on 2026-10-26: net profit +93.97% year on year, +111.34% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved -3.58% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-26
- Period end
- 2026-09-30
- Net profit YoY
- +93.97%
- Excl. one-offs YoY
- +111.34%
- Net profit QoQ
- +163.77%
- Result
- Great
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -0.87% | — |
| 3 days | -3.58% | — |
| 7 days | +0.29% | — |
| 14 days | -6.73% | — |
Report history
Over the last 8 reports, net profit grew year on year in 3 of them. The stock rose in the 3 trading days after 4 of 6 reports (average +0.88%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-27 | ¥95.35M | +93.97% | +111.34% | -10.79% | 0.09 | 0.99% | -3.58% | — | — |
| 2026 interim report | 2026-08-22 | ¥50.39M | +34.25% | +51.93% | -8.55% | 0.05 | 0.52% | +3.61% | +1.07% | +7.99% |
| 2026 Q1 report | 2026-04-22 | ¥33.34M | +48.61% | +25.35% | -2.18% | 0.03 | 0.35% | +1.37% | -13.94% | -15.52% |
| 2025 annual report | 2026-04-22 | ¥70.33M | -65.12% | -70.23% | +0.81% | 0.06 | 0.73% | +1.37% | -13.94% | -15.52% |
| 2025 Q3 report | 2025-10-28 | ¥49.16M | -86.00% | -90.82% | +2.24% | 0.04 | 0.51% | +0.60% | -6.03% | -2.66% |
| 2025 interim report | 2025-08-22 | ¥37.53M | -77.30% | -84.85% | +15.81% | 0.03 | 0.39% | +5.50% | -9.75% | -17.55% |
| 2025 Q1 report | 2025-04-21 | ¥22.43M | -58.51% | +17.56% | +42.85% | 0.02 | 0.23% | -2.25% | +2.32% | -0.63% |
| 2024 annual report | 2025-04-21 | ¥201.65M | -76.59% | -65.93% | -23.75% | 0.18 | 2.11% | -2.25% | +2.32% | -0.63% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.